EN
HI

LINCOLN PHARMA Share price

LINCOLN

HealthcareSmall

599.45

0.00 (0.00%)
NSE
BSE
Last updated on 16 May, 2025 | 15:52 IST
BUYSELL
Today's High

609.70

Today's Low

594.10

52 Week Low

499.00

52 Week High

979.50

The current prices are delayed, login to your account for live prices

Lincoln Pharmaceuticals Chart

LINCOLN PHARMA Fundamentals

P/E Ratio

13.48

P/B Ratio

1.83

Div. Yield

0.3

Sector P/E

41.77

Sector P/B

4.72

Sec. Div. Yield

0.32

LINCOLN PHARMA Resistance and Support

Pivot 601.08

Resistance

First Resistance

608.06

Second Resistance

616.68

Third Resistance

623.66

Support

First Support

592.46

Second Support

585.48

Third Support

576.86

LINCOLN PHARMA Futures & Options

Data Not Found

LINCOLN PHARMA Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    49.78%

    Mutual Fund

    0%

    Insurance

    0%

    Foreign Institutional Investors

    5%

    Domestic Institutional Investors

    0.01%

    Retail

    45.22%

    Others

    -0.01%

    Total Promoters
    MAR '25
    49.78%

    LINCOLN PHARMA Corporate Actions

    DateAgenda
    2025-05-22Audited Results & Final Dividend
    2025-02-13Quarterly Results
    DateEvent TypeAgenda
    2025-05-22Board MeetingAudited Results & Final Dividend
    2025-02-13Board MeetingQuarterly Results

    LINCOLN PHARMA News

    Lincoln Pharmaceuticals Ltd enters elite league; Enters Rs. 1,000 crore plus market cap club

    Aug 29 2023 17:37:24
    Read More

    About LINCOLN PHARMA AboutThe

    NSE : 11596  
    BSE : 531633  
    ISIN : INE405C01035  

    The Company was incorporated as a public limited company by converting partnership concern M/s. Lincoln Pharmaceuticals under Part IX of the Companies Act 1956. M/s.Lincoln Pharmaceuticals was established as a partnership firm on 18th January 1979 with Mr. Rajni G. Patel Mr. Hasmukhbhai I.Patel Mrs. Hansaben A.Patel Mrs. Jivtiben C.Patel Mrs.Jiviben T.Patel and Mrs. Lilaben T. Patel as partners with its main object of manufacturing pharmaceutical formulations. The business was started in Naroda G.I.D.C estate. Further on 9.12.81 Mr.Mihir V. Patel Mr.Maheshbhai M.Patel Mr.Yogeshkumar I. Patel and Mrs.Madhuben V.Patel were admitted as Partners. The firm was carrying on its business by getting its products manufactured on Loan and Licence Basis from 1979 to 1982.All the partners decided and agreed vide resolution dated 30.10.94 that all members of Co-partnership should register the said firm as public limited company for sake of smooth working better and effective management and improvement and advancement of business. It was also decided as per the said resolution that such company should carry Out and continue the existing business of the firm. As a result anthe incorporation of the Company on 20th January 1995 all the properties of the firm (movable & immovable) and all the liabilities of the firm 55 an the closing of the business of the day proceeding the date of incorporation of the Company vested in the Company. Since date of incorporation of the Company i.e 20th January 1995 all the assets and liabilities aforesaid as on 19th January 1995 vested in the Company. Company is carrying on running business of erstwhile M/s. Lincoln Pharmaceuticals having its formulations production facilities at Naroda GIDC Ahmedabad Gujarat of manufacturing tablets capsules liquid and powder syrups and ointments. Company is alsogetting its products manufactured on "Loan and License" basis from other manufacturers to meet the demand of small volume parenterals.The Company has now decided to establish modern formulations manufacturing plant at Village: Khatraj. Tal:Kalol Olaf. Mehsana in Gujarat to manufacture small volume parenterals like Dry powder injectables liquid vial liquid ampoules and eye drops and expand itsproduction capacities of manufacturing tablets capsules liquid/powder syrups and ointment and also to establish fully equipped laboratory to undertake in house testing of its products for better quality control and give thrust on Research and Development. Company has already acquired N.A land Adm: 8833 Sq. Mtrs. and is in the process of acquiring further land adm. aprox.11170 Sq.Mtrs. Company has givenadvance for booking cement and steel and are preparing to commence construction of factory building at new site. Company has identified all plant and machineries and has also given advance to major plant & machinery suppliers far those machineries which has longer delivery period so as to implement the project an time. The company has existing manufacturing facilities at Naroda and if is alreadyselling its products all over India and is having thrust in the markets of Gujarat Rajasthan Andhra Pradesh Bihar and Jammu.

    LINCOLN PHARMA Management

    NamePosition
    Mr. Kishor M Shah Non Executive Chairman
    Mr. Mahendra G Patel Managing Director
    Mr. Hashmukh I Patel Whole Time Director
    Mr. Munjal M Patel Whole Time Director
    Mr. Ashish R Patel Whole Time Director
    Read More

    LINCOLN PHARMA FAQs

    LINCOLN PHARMA शेयर का खरीद मूल्य 599.45 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    LINCOLN PHARMA शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    LINCOLN PHARMA शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 13.48 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    LINCOLN PHARMA शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 1.83 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    LINCOLN PHARMA शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.72 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    LINCOLN PHARMA का मार्केट कैप 1200.68 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    LINCOLN PHARMA शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 979.50 और 499.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    LINCOLN PHARMA Share Key Metrics

    Volume
    40031.00
    Market Cap
    1200.68 CR
    LTQ@LTP
    1@599.45
    ATP
    601.69
    Var Margin
    22.12 %
    Circuit Range
    479.6-719.3
    Delivery %
    56.7 %
    Value
    2.41 CR
    ASM/GSM
    No
    Market Lot
    1